TDACU
Translational Development Acquisition Corp.
NASDAQ · Financial Services · Shell Companies · US
$11.48
+0.00%Price chart
Sep 17Sep 22Sep 25Sep 30Oct 5Oct 8Oct 13Oct 16
Key dataOct 16, 2026
Open$11.48
From 52W high−33.60%
Volume0.00
Market cap$302.00M
P/E (TTM)19.2x
P/S (TTM)—
Div yield—
Key dataOct 16, 2026
Open
$11.48
From 52W high
−33.60%
Volume
0.00
Market cap
$302.00M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−319.9x
P/E (TTM)
19.2x
RSI (14)
14.6
MomentumView details →
1D Return
+0.00%
YTD Return
+9.96%
Similar companies
Latest newsMore news →
ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.85d agoTranslational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.107d ago